Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury - PubMed (original) (raw)

. 1993 Apr;142(4):1217-26.

Affiliations

Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury

A Seekamp et al. Am J Pathol. 1993 Apr.

Abstract

Ischemia followed by reperfusion in rat limb results in evidence of vascular injury in the limb as well as in the lung as measured by leakage of [125I]albumin and extravasation of [51Cr] red blood cells. Vascular injury in lung and limb was proportional to the time of limb reperfusion and was associated with accumulation of myeloperoxidase, as well as evidence of complement consumption. In this model, the rank order of protective interventions was: neutrophil depletion > catalase + superoxide dismutase = allopurinol > dimethylthiourea = dimethylsulfoxide > deferoxamine = complement depletion. These data suggest that toxic oxygen products of neutrophils are related to the development of vascular injury. There was a reasonable correlation between protective effects of interventions and reduced tissue content of myeloperoxidase. Systemic treatment with the L-arginine antagonists, NG-monomethyl-L-arginine or nitro-L-arginine methyl ester, was also protective against vascular injury, suggesting that metabolic products of L-arginine participate in events leading to injury.

PubMed Disclaimer

References

    1. Ann Thorac Surg. 1969 Jun;7(6):539-49 - PubMed
    1. J Cell Physiol. 1992 Jun;151(3):506-11 - PubMed
    1. Blood. 1981 Sep;58(3):658-61 - PubMed
    1. Hum Pathol. 1983 Apr;14(4):338-42 - PubMed
    1. J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1154-60 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources